DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Agache I, Rocha C, Beltran J. et al.
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Allergy 2020;
75 (05) 1043-1057
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.